I think the opportunity in the US market lays with MVM selling bespoke bulk IF formula to manufacturers In the US. I understand MVM already have FDA approval for some of their products so this scenario is quite possible.
it would also resolve the issue of operating MVM at its full capacity in the short term
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)